AIMOVIG vs DUETACT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. AIMOVIG and DUETACT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	DUETACT
Rating	72/100	New
Pharmacy pays	—	~$0.91 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	GLIMEPIRIDE AND PIOGLITAZONE HYDROCHLORIDE
Manufacturer	Amgen Inc	Takeda Pharms USA
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	Boxed warning
Half-life	—	about 3 to 7 hours (parent drug)

aimovig duetact

Rating

72/100

New

Pharmacy pays

—

~$0.91 /30

Type

Active ingredient

ERENUMAB-AOOE

GLIMEPIRIDE AND PIOGLITAZONE HYDROCHLORIDE

Manufacturer

Amgen Inc

Takeda Pharms USA

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Boxed warning

Half-life

—

about 3 to 7 hours (parent drug)

Frequently asked questions

What is the difference between Aimovig and Duetact?

Aimovig contains Erenumab-Aooe, while Duetact contains Glimepiride and Pioglitazone Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.